SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tüzün, S.
Right arrow Articles by Siva, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tüzün, S.
Right arrow Articles by Siva, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Bone status in multiple sclerosis: beyond corticosteroids

Sansin Tüzün

Department of Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey, sansin{at}veezy.com

Ayse AltWntas

Department of Neurology, Division of Clinical Neuroimmunology, Multiple Sclerosis Clinic, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey

Ilhan Karacan

Physical Medicine and Rehabilitation Clinic, SSK VakWf Gureba Hospital, Istanbul, Turkey

Saliha Tangürek

Department of Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey

Sebahattin Saip

Department of Neurology, Division of Clinical Neuroimmunology, Multiple Sclerosis Clinic, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey

Aksel Siva

Department of Neurology, Division of Clinical Neuroimmunology, Multiple Sclerosis Clinic, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey

The aim of this study was to determine the possible factors affecting bone mineral density (BMD) in multiple sclerosis (MS). In this cross-sectional study, 65 clinically definite MS patients and 72 comparable controls were prospectively evaluated. To assess bone mineral metabolism in MS, the BMD of the lumbar spine and hip (femoral neck, trochanter and total) was measured by dual-energy X-ray absorptiometry, and serum vitamin D and parathyroid hormone levels and biochemical markers of bone turnover were also evaluated. MS patients had significantly lower BMD values than the control group at all measurement sites. There was a significant correlation between the disease duration and BMD values at the trochanter in women with MS. A correlation between femoral BMD values and functional status in women was also detected. There was no relationship between bone biochemical markers and BMD, except a negative correlation between bone alkaline phosphatase and trochanter BMD. Both disability and disease duration have an influence on BMD of the MS patients, whereas no significant correlation between glucocorticoid use and BMD was observed.

Key Words: bone density • disability • disease duration • glucocorticoids • multiple sclerosis

Multiple Sclerosis, Vol. 9, No. 6, 600-604 (2003)
DOI: 10.1191/1352458503ms966oa
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement